CIK 0001347178 · Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 030491827
- Phone
- 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-17 | DUGAN RICHARD W Director | Grant or award | +20,529 | 118,229 | ||
| 2024-05-17 | DUGAN RICHARD W Director | Grant or award · Stock Option (Right to Buy) | +37,578 | 37,578 | ||
| 2024-05-17 | Mitchell Stephen Ray Director | Grant or award | +20,529 | 49,857 | ||
| 2024-05-17 | Mitchell Stephen Ray Director | Grant or award · Stock Option (right to buy) | +37,578 | 37,578 | ||
| 2024-05-17 | Ward Anne Sempowski Director | Grant or award | +20,529 | 59,842 | ||
| 2024-05-17 | Ward Anne Sempowski Director | Grant or award · Stock Option (right to buy) | +37,578 | 37,578 | ||
| 2024-03-05 | Williams Timothy SVP & General Counsel | Sale | −8,941 | $4.18 | $37K | 196,825 |
| 2024-03-05 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | −9,229 | $4.21 | $39K | 129,789 |
| 2024-03-05 | Polymeropoulos Mihael Hristos President and CEO | Sale | −24,288 | $4.13 | $100K | 1,871,730 |
| 2024-03-05 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −8,902 | $4.20 | $37K | 231,014 |
| 2024-03-05 | Birznieks Gunther SVP, Business Development | Sale | −8,684 | $4.13 | $36K | 313,569 |
| 2024-03-04 | Williams Timothy SVP & General Counsel | Sale | −8,147 | $4.41 | $36K | 205,766 |
| 2024-03-04 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | −7,498 | $4.41 | $33K | 139,018 |
| 2024-03-04 | Polymeropoulos Mihael Hristos President and CEO | Sale | −30,884 | $4.24 | $131K | 1,896,018 |
| 2024-03-04 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −5,798 | $4.48 | $26K | 239,916 |
| 2024-03-04 | Birznieks Gunther SVP, Business Development | Sale | −8,727 | $4.30 | $37K | 322,253 |
| 2024-02-16 | Williams Timothy SVP & General Counsel | Grant or award | +125,000 | 213,913 | ||
| 2024-02-16 | Wijkstrom Joakim SVP, Chief Marketing Officer | Grant or award | +32,700 | 146,516 | ||
| 2024-02-16 | Polymeropoulos Mihael Hristos President and CEO | Grant or award | +450,000 | 1,926,902 | ||
| 2024-02-16 | Moran Kevin Patrick SVP, CFO & Treasurer | Grant or award | +125,000 | 245,714 |
Page 4 of 8 · 153 trades